Institutional Development Award (IDeA) for Clinical & Translational Research (CTR)
ID: 360883Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Private Institutions of Higher Education

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360883
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Institutional Development Award (IDeA) for Clinical & Translational Research (CTR), aimed at enhancing biomedical research capacity in states with historically low NIH funding. This grant program supports two tracks: the IDeA Clinical and Translational Research Development (CTR-D) awards, which focus on workforce development and infrastructure enhancement, and the IDeA Clinical & Translational Research Network (CTR-N) awards, which aim to build statewide or multi-state networks to improve clinical research capabilities. This initiative is crucial for addressing health challenges prevalent in IDeA states, which include Alaska, Arkansas, and others, and is open to private institutions of higher education that meet specific eligibility criteria. Interested applicants can reach out to NIGMS IDeA CTR via email at NIGMS_IDeA-CTR@mail.nih.gov for further information, with the estimated project start date set for July 16, 2027, and the application deadline anticipated to close on October 9, 2026.

    Files
    No associated files provided.
    Similar Opportunities
    IDeA Networks of Biomedical Research Excellence (INBRE)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "IDeA Networks of Biomedical Research Excellence (INBRE)" aimed at enhancing biomedical research capacity in states that have historically received low levels of NIH funding. This program seeks to support statewide networks consisting of research-intensive institutions and primarily undergraduate institutions (PUIs) in designated IDeA states, fostering collaboration, faculty research, student participation, and institutional research infrastructure development. Eligible applicants include private institutions of higher education located in specific states such as Alaska, Arkansas, and Puerto Rico, among others, with no cost-sharing or matching requirement. Interested parties can reach out to Dr. Jessica M. Faupel-Badger at 301-480-4969 or via email at badgerje@mail.nih.gov for further information. The estimated project start date is May 1, 2028, with applications closing on May 18, 2027.
    Infectious Diseases Clinical Trials Network (IDCTN)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a cooperative agreement opportunity titled "Infectious Diseases Clinical Trials Network (IDCTN)" aimed at advancing public health through the rapid implementation of clinical trials for infectious diseases. This initiative seeks to establish a network comprising Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC) to evaluate therapeutics, vaccines, diagnostics, and devices, addressing urgent public health needs that standard grant timelines cannot meet. With an estimated total program funding of $29 million, this opportunity is open to a wide range of eligible applicants, including Indian/Native American Tribal Governments, federal agencies, and community-based organizations. Interested parties can reach out to Dr. Marina S. Lee at 240-627-3304 or via email at dmidclinicaltrials@niaid.nih.gov for further information, with key deadlines including an estimated synopsis close date of June 11, 2026, and an anticipated award date of March 1, 2027.
    Centers of Biomedical Research Excellence: Development Phase (COBRE-D)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Centers of Biomedical Research Excellence: Development Phase (COBRE-D)" aimed at enhancing biomedical research capacity in IDeA-eligible states. This program is designed to support institutions in these states by providing funding to recruit and mentor early-career investigators, establish research facilities, and improve research administration support services, thereby addressing the limited infrastructure and expertise in broad scientific areas of strategic importance. The COBRE-D program serves as a foundational step for less-resourced institutions to transition into the more advanced Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S) program. Interested applicants, specifically private institutions of higher education located in designated IDeA states, should note that the estimated project start date is July 1, 2027, with applications due by September 28, 2026. For further inquiries, contact Dr. Federico Bernal at federico.bernal@nih.gov or call 240-271-5059.
    Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S)" aimed at enhancing biomedical research capacity in IDeA-eligible institutions. This program supports the expansion of research centers and the sustainability of existing infrastructures by encouraging institutions to grow their faculty base and develop research projects and core facilities in strategic scientific areas. The initiative is particularly significant for institutions in states that have historically received low levels of NIH funding, fostering advancements in health-related sciences. Interested applicants, specifically private institutions of higher education located in designated IDeA-eligible states, should prepare to submit their proposals by May 26, 2026, with an estimated award date of April 1, 2027. For further inquiries, contact Dr. Federico Bernal at federico.bernal@nih.gov or call 240-271-5059.
    Clinical and Translational Science Award (UM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at enhancing clinical and translational research through collaborative partnerships. This initiative invites applications for hubs that will focus on improving the efficiency of clinical translation, addressing health disparities, and fostering innovative research methodologies, with a particular emphasis on community engagement and workforce development. Successful applicants, which may include higher education institutions and nonprofit organizations, are expected to outline strategic management and demonstrate strong leadership, with projects capped at seven years and a submission deadline of September 28, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the funding opportunity page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html.
    Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition funding opportunity titled the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research through collaborative efforts among multiple medical research institutions. This initiative seeks to support the development, implementation, and dissemination of innovative solutions that address urgent public health needs and promote health equity, requiring applicants to include at least three eligible organizations to foster interdisciplinary partnerships. Eligible projects can receive funding of up to $650,000 annually for a total duration of up to five years, with applications due by October 19, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-296.html.
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Funding Opportunity titled "High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development of unique capabilities and resources to address critical gaps in clinical and translational science within awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs. The funding opportunity, numbered PAR-25-156, allows for project budgets of up to $500,000 per year over a project period of up to five years, with applications involving clinical trials being optional. Interested applicants, primarily from public and state-controlled institutions of higher education, must submit detailed integration plans, milestones, and sustainability evaluations by the closing date of September 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at training individuals with clinical doctoral degrees for impactful careers in health-related research, particularly in cancer studies. This program is designed to support individuals from underrepresented backgrounds in health-related sciences, providing them with a mentored research career development experience over a period of 3 to 5 years, focusing on biomedical, behavioral, and clinical research, including clinical trials. Successful applicants are expected to commit at least 75% of their time to the project and will receive funding for salary and research-related expenses, with applications due at specific intervals starting January 12, 2025. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-319.html.
    Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Translational Research Training Program (T32), a federal grant aimed at equipping advanced predoctoral students, postdoctoral fellows, and fellowship-stage clinicians with the skills necessary to advance basic research toward clinical application, particularly in the field of neuroscience. This program emphasizes a cohesive educational approach that integrates training in experimental design, statistical analysis, and effective communication, while fostering interdisciplinary collaboration among scientists and clinicians and providing exposure to industry and regulatory processes. The grant will cover stipends, tuition, and training-related expenses for a duration of two years, with a focus on enhancing diversity in biomedical research. Interested applicants can find more information and apply by May 25, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development and demonstration of innovative resources and capabilities within Clinical and Translational Science Awards (CTSA) Program hubs, specifically targeting critical gaps and roadblocks in clinical research. Successful applicants, who must be active UM1 CTSA award recipients, will propose projects lasting up to five years with an annual budget cap of $500,000, emphasizing collaboration and innovation in health research. Interested parties should note that the application deadline is September 14, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.